Pacini Furio

Dr. Furio is currently Professor, Director of Endocrinology at University of Siena. he is specialized in endocrinology. His research interests are thyroid pathophysiology, Molecular diagnostics of thyroid nodules, Genetics of thyroid carcinomas, Relationships between thyroid autoimmunity and cancer, Experimental therapy of thyroid tumors aggressive.

His publications are as follows:

F. Pacini, T. Vorontsova, EP. Demidchik, E. Molinaro, L. Agate, C. Romei, E. Shavrova, ED. Cherstvoy, Y. Ivashkevitch, E. Kuchinskaya, M. Schlumberger, G. Ronga, M. Filesi, A. Pinchera. Post-Chernobyl thyroid carcinoma in Belarus children and adolescents: comparison with naturally occurring thyroid carcinoma in Italy and France. J Clin Endocrinol Metab, 82:3563-9, 1997.
F. Pacini, A. Vivaldi, M. Santoro, M. Fedele, A. Fusco, C. Romei, F. Basolo, A. Pinchera. Simian virus 40-like DNA sequences in human papillary thyroid carcinomas. Oncogene, 16:665-9, 1998.
F. Pacini, T. Vorontsova, E. Molinaro, E. Kuchinskaya, L. Agate, E. Shavrova, L. Astachova, L. Chiovato, A. Pinchera. Prevalence of thyroid autoantibodies in children and adolescents from Belarus exposed to the Chernobyl radioactive fallout. The Lancet, 352:763-6, 1998.
Elisei R, Romei C, Vorontsova T, Cosci B, Veremeychik V, Kuchinskaya E, Basolo F, Demidchik EP, Miccoli P, Pinchera A, Pacini F. Ret/ptc rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults. J Clin Endocrinol Metab 86:3211-6, 2001.
Ceccarelli C, Bencivelli W, Morciano D, Pinchera A, Pacini F. 131-Therapy for differentiated thyroid cancer leads to an earlier onset of menopause: results of a retrospective study. J Clin Endocrinol Metab 86:3512-5, 2001.
Pacini F, Agate L, Elisei R, Capezzone M, Ceccarelli C, Lippi F, Molinaro E, Pinchera A. Outcome of differentiated thyroid cancer with detectable serum Tg and negative diagnostic 131-I whole body scan: comparison of patients treated with high 131-I activities versus untreated patients. J Clin Endocrinol Metab 86:4092-7, 2001.
Pacini F, Molinaro E, Lippi F, Castagna MG, Agate L, Ceccarelli C, Taddei D, Elisei R, Capezzone M, Pinchera A. Prediction of disease status by recombinant human TSH-stimulated serum Tg in the postsurgical follow-up of differentiated thyroid carcinoma. J Clin Endocrinol Metab 86:5686-90, 2001.
Pacini F, Capezzone M, Elisei R, Ceccarelli C, Taddei D, Pinchera A. Diagnistic 131-Iodine whole-body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment. J Clin Endocrinol Metab 87:1499-1501, 2002.